Comments

HOOKIPA Pharma Insider Trading Activity

HOOKOTCID
Logo brought to you by Benzinga Data
Trade with Public
Trade with Public
$0.8403
At close: Aug 15, 5:00 PM EST
OverviewNewsEarningsOptionsAnalyst Ratings

Insider Trades

Short Interest

HOOKIPA Pharma Insider Trading Activity | OTC:HOOK | Benzinga

Track the latest HOOKIPA Pharma insider trading activity. Stay informed on recent buys, sells, and market impact for HOOKIPA Pharma stock.

What is Insider Activity?

Insider trading activity involves company insiders, such as executives, directors, and employees, engaging in transactions of their own company's stock. Insiders' buy and sell transactions provide valuable insights into their confidence in the company's future performance.

What are HOOKIPA Pharma Inc Insiders Doing?

Insiders have report no purchases/sales in the last 30 days.

Notable Recent Insider Buys and Sales

  • On October 9, 2025, Malte Peters, the company's CHIEF EXECUTIVE OFFICER sold 25.17K shares for $0.82 each.

Ownership Statistics for HOOKIPA Pharma Inc

Shares Outstanding
12.330M
Insider Shares Owned
569.357K
Insider Percentage Owned
4.62%
Institutional Shares Held
238.830K
Institutional Percentage Held
1.94%
Oct 09, 2025Malte PetersCHIEF EXECUTIVE OFFICER-25.17K$0.82-$20.68KSELL-31.66%54.35KAug 19View
Jul 23, 2025Malte PetersCHIEF EXECUTIVE OFFICER-29.18K$0.92-$26.84KSELL-26.84%79.52KJul 22View
Jul 23, 2025Mary Theresa CoelhoEVP AND CFO-13.61K$0.92-$12.52KSELL-19.48%56.27KJul 22View
Aug 22, 2023Reinhard KanderaCHIEF FINANCIAL OFFICER7.00K$0.72$5.08KBUY19.39%43.09KAug 21View
Aug 17, 2023Reinhard KanderaCHIEF FINANCIAL OFFICER8.00K$0.71$5.71KBUY28.48%36.09KAug 16View
Jul 11, 2023Jorn AldagCHIEF EXECUTIVE OFFICER10.00K$0.82$8.19KBUY16.14%71.95KJul 07 - Jul 11View
Jul 07, 2023Jorn AldagCHIEF EXECUTIVE OFFICER5.00K$0.89$4.45KBUY8.78%61.95KJul 05View
Jul 05, 2023Jorn AldagCHIEF EXECUTIVE OFFICER5.00K$0.89$4.46KBUY9.62%56.95KJul 03View
Jul 03, 2023Reinhard KanderaCHIEF FINANCIAL OFFICER12.00K$0.88$10.56KBUY74.57%28.09KJun 30View
Jan 12, 2022Igor MatushanskyCHIEF MEDICAL OFFICER7.90K$1.30-$34.94KSELL-OPTIONS10.21%85.31KDec 21View
Apr 23, 2021Monique Saulnier Name: Monique Saulnier, Title: Managing Partner of Sofinnova Partners SASSofinnova Partners SAS10% OWNER-328.62K$11.60-$3.81MSELL-9.37%3.18MApr 21View
Mar 31, 2021Monique Saulnier Name: Monique Saulnier, Title: Managing Partner of Sofinnova Partners SASSofinnova Partners SAS10% OWNER-36.83K$13.67-$503.57KSELL-1.04%3.51MMar 29View
Mar 31, 2021Monique Saulnier Name: Monique Saulnier, Title: Managing Partner of Sofinnova Partners SASSofinnova Partners SAS10% OWNER-35.17K$13.69-$481.64KSELL-0.98%3.54MMar 26View
Mar 29, 2021Monique Saulnier Name: Monique Saulnier, Title: Managing Partner of Sofinnova Partners SASSofinnova Partners SAS10% OWNER-28.55K$13.12-$374.57KSELL-0.79%3.58MMar 25View
Mar 26, 2021Monique Saulnier Name: Monique Saulnier, Title: Managing Partner of Sofinnova Partners SASSofinnova Partners SAS10% OWNER-52.69K$13.70-$721.62KSELL-1.44%3.61MMar 24View
Mar 25, 2021Monique Saulnier Name: Monique Saulnier, Title: Managing Partner of Sofinnova Partners SASSofinnova Partners SAS10% OWNER-40.00K$13.91-$556.48KSELL-1.08%3.66MMar 23View
Mar 24, 2021Monique Saulnier Name: Monique Saulnier, Title: Managing Partner of Sofinnova Partners SASSofinnova Partners SAS10% OWNER-40.53K$14.54-$589.26KSELL-1.08%3.70MMar 22View
Mar 23, 2021Monique Saulnier Name: Monique Saulnier, Title: Managing Partner of Sofinnova Partners SASSofinnova Partners SAS10% OWNER-166.23K$14.60-$2.43MSELL-4.26%3.74MMar 19View
Dec 18, 2020Igor Matushansky—21.27K$5.92-$327.83KOPTION EXERCISE37.89%77.40KDec 16 - Dec 17View
Oct 06, 2020Monique Saulnier Name: Monique Saulnier, Title: Managing Partner of Sofinnova Partners SASSofinnova Partners SAS—-300.00$10.00-$3.00KSELL-0.01%3.91MOct 02View
Sep 17, 2020Monique Saulnier Name: Monique Saulnier, Title: Managing Partner of Sofinnova Partners SASSofinnova Partners SAS—-41.60K$12.61-$524.48KSELL-1.05%3.91MSep 15View
Jul 22, 2020Monique Saulnier Name: Monique Saulnier, Title: Managing Partner of Sofinnova Partners SASSofinnova Partners SAS—-3.28K$11.78-$38.63KSELL-0.08%3.96MJun 29View
Jul 22, 2020Monique Saulnier Name: Monique Saulnier, Title: Managing Partner of Sofinnova Partners SASSofinnova Partners SAS—-12.48K$11.94-$149.10KSELL-0.32%3.95MJul 20View
Jul 01, 2020Monique Saulnier Name: Monique Saulnier, Title: Managing Partner of Sofinnova Partners SASSofinnova Partners SAS—-3.28K$11.78-$38.63KSELL-0.08%3.96MJun 29View
Jan 31, 2020Igor Matushansky—-5.50K$12.73-$69.99KSELL-9.34%53.40KJan 29View
Jan 27, 2020Anders LiljaSR. VP, TECHNICAL DEVELOPMENT0.00$6.34-$145.37KSELL-OPTIONS0.00%0.00Jan 23View
Jan 21, 2020Klaus OrlingerSR. VP, RESEARCH0.00$6.01-$100.52KSELL-OPTIONS0.00%0.00Jan 16 - Jan 21View
Jan 16, 2020Klaus OrlingerSR. VP, RESEARCH0.00$5.70-$95.20KSELL-OPTIONS0.00%0.00Jan 14View
Dec 23, 2019Igor MatushanskyCHIEF MEDICAL OFFICER15.49K$5.01-$100.72KSELL-OPTIONS35.68%58.90KDec 19View
Dec 19, 2019Igor MatushanskyCHIEF MEDICAL OFFICER14.83K$3.98-$87.75KSELL-OPTIONS51.88%43.41KDec 17View
Apr 25, 2019Forbion Forbion10% OWNER2.48M$14.00$749.99KBUY26678.75%2.49MApr 23View
Apr 25, 2019Monique Saulnier Name: Monique Saulnier, Title: Managing Partner of Sofinnova Partners SASSofinnova Partners SAS10% OWNER3.88M$14.00$5.00MBUY4707.24%3.96MApr 23View
Apr 23, 2019BAKER BROS ADVISORS LPBaker Bros Advisors GP LLCFELIX BAKERJULIAN BAKER—892.86K$14.00$12.50MBUY∞820.73KApr 23View

FAQ

Q

Is insider trading legal?

A
Insider trading is legal so long as the insiders report those trades to the SEC. Illegal securities trading occurs when the insider is violating a fiduciary duty or fails to report their trades.
Q

What are some examples of market manipulation?

A
Insider trading, pump and dump schemes, front running and wash trades are all examples of market manipulation. Investors who track insider asset movement should think carefully about why these insiders are trading their stocks before moving forward.

Browse insider trades on all stocks.

Connect With Us
instagramlinkedinyoutubeblueskymastodon
About Benzinga
Market Resources
Trading Tools & Education
Ring the Bell
© 2025 Benzinga | All Rights Reserved